Supernus Pharmaceuticals
SUPN
SUPN
305 hedge funds and large institutions have $2.76B invested in Supernus Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 62 funds opening new positions, 89 increasing their positions, 117 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
3.36% less ownership
Funds ownership: 106.22% → 102.87% (-3.4%)
24% less repeat investments, than reductions
Existing positions increased: 89 | Existing positions reduced: 117
Holders
305
Holding in Top 10
4
Calls
$11.5M
Puts
–
Top Buyers
| 1 | +$59.9M | |
| 2 | +$59.3M | |
| 3 | +$23.5M | |
| 4 |
D.E. Shaw & Co
New York
|
+$18.2M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$16.2M |
Top Sellers
| 1 | -$94.4M | |
| 2 | -$32M | |
| 3 | -$31.6M | |
| 4 |
ACB
Aristotle Capital Boston
Boston,
Massachusetts
|
-$24M |
| 5 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$20.2M |
